Cancers that
keep coming back…

Meet doctors
who never give up

Clinicians

Omico provides free Comprehensive Genomic Profiling (CGP) to patients with advanced, incurable or an earlier diagnosis of a poor prognosis cancer, to identify potential matches to clinical trials with new targeted therapies. 

Through our national and international partnerships, Omico is attracting more international precision oncology trials to Australia to increase treatment options for patients.

Cancer Meet Its Match

Opportunities for the clinical community

video_icon

Why collaborate with Omico?

1

CGP at no cost
Access comprehensive genomic profiling at no cost to your patient to help identify potential clinical trial and treatment options.

2

Expert therapy/trial recommendations
Receive expert-reviewed therapy and clinical trial matching recommendations.

3

Trial identification and prioritisation
Access support to identify and prioritise relevant clinical trial options for your patients.

4

Help establish biomarker-led clinical trials that may not otherwise be feasible due to low patient numbers.

How our Cancer Screening Program (CaSP) works

If you or someone you know has advanced, incurable or an earlier diagnosis of a poor prognosis cancer, they may be eligible for CaSP. 

  • The clinician submits an online referral form
  • The patient provides informed consent 
  • Omico coordinates comprehensive genomic profiling 
  • Results are reviewed by our Molecular Oncology Board 
  • Potential treatment and clinical trial options are identified 
  • Results and recommendations are returned to the treating clinician
Learn more about CaSP Learn more about our precision oncology programs

FAQs

  • Is my patient eligible for CaSP?

    If you answer “yes” to the following statements your patient may be eligible for enrolment.

    Your patient:

    • is aged 16 years or older, with pathologically confirmed advanced and/or metastatic cancer of any histologic type or an earlier diagnosis of a poor prognosis cancer
    • has tissue available for genomic profiling
    • is self-caring in all activities of daily living, and out of bed more than half of each day (ECOG performance status 0, 1 or 2)

  • How do I refer a patient?

    To refer a patient to CaSP, you will need to:

    • Complete the referral form using the link below.
    • Provide the patient’s histopathology report and any relevant clinical information.
    • Receive and discuss the molecular screening test results and MOB report with your patient.
    • If appropriate, refer your patient to a clinical trial or follow up on treatment options identified in the MOB report.
    • Continue to provide us with follow-up information about your patient.

    CaSP program referral form

  • What are the specimen requirements for CaSP?

    Download our guide to CaSP optimal specimen requirements.

Explore more

Our Progress

37,311 People referred to Omico programs
17,654 Participants with a treatment recommendation, of the 24,984 who have had CGP to date (70.7%)
1,546 Participants accessing a clinical trial or matched therapy
1,567 Referring Clinicians

Refer your eligible patient for free comprehensive genomic profiling and treatment matching through Omico.

Get in touch